Abstract
Detailed investigation was made of the triacylglycerol structure of three varieties of peanut oils of varying atherogenic activity. By means of chromatographic and stereospecific analyses, it was shown that all the oils had markedly nonrandom enantiomeric structures with the long chain saturated fatty acids (C20−C24) confined exclusively to thesn-3-position, whereas the palmitic and oleic acids were distributed about equally between thesn-1-andsn-3-positions, with the linoleic acid being found preferentially in thesn-2-position. On the basis of detailed studies of the molecular species of the separatesn-1,2-,sn-2,3- andsn-1,3-diacylglycerol moieties, it was concluded that the fatty acids in the three positions of the glycerol molecule are combined with each other solely on the basis of their relative molar concentrations. As a result, it was possible to calculate the composition of the molecular species of the peanut oil triacylglycerols (including the content of the enantiomers and the reverse isomers) by means of the 1-random 2-random 3-random distribution. In general, the three peanut oils possessed triacylglycerol structures which where closely similar to that derived earlier for a commercial peanut oil of North American origin. Since their oil has exhibited a high degree of atherogenic potential, it was anticipated that the present oils would likewise be atherogenic, which has been confirmed by biological testing. However, there are certain differences in the triacylglycerol structures among these oils, which can be correlated with the variations in their atherogenic activity. The major differences reside in the linoleic/oleic acid ratios in the triacylglycerols, especially in thesn-2-position, and in the proportions in which these acids are combined with the long chain fatty acids. On the basis of the characteristic structures identified in the earlier analyzed atherogenic peanut oil, the peanut oil of South American origin would be judged to possess the greatest atherogenic potential and this has been borne out by biological testing.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Kritchevsky, D., Tepper, S.A., Vesselinovitch, D., and Wissler, R.W. (1973) Atherosclerosis 14, 53–64.
Kritchevsky, D., Tepper, S.A., Vesselinovitch, D., and Wissler, R.W. (1973) Atherosclerosis 17, 225–243.
Myher, J.J., Marai, L., Kuksis, A., and Kritchevsky, D. (1977) Lipids 12, 775–785.
Kritchevsky, D., Tepper, S.A., Scott, D.A., Klurfeld, D.M., Vesselinovitch, D., and Wissler, R.W. (1981) Atherosclerosis 38, 291–299.
Myher, J.J., and Kuksis, A. (1979) Can. J. Biochem. 57, 117–124.
Kuksis, A., Breckenridge, W.C., Myher, J.J., and Kakis, G. (1978) Can. J. Biochem. 56, 630–639.
Myher, J.J., Kuksis, A., Marai, L., and Yeung, S.K.F. (1978) Anal. Chem. 50, 557–561.
Myher, J.J., Kuksis, A., Vasdev, S.C., and Kako, K.J. (1979) Can. J. Biochem. 57, 1315–1327.
Kuksis, A., Marai, L., and Myher, J.J., (1973) J. Am. Oil Chem. Soc. 50, 193–201.
Kuksis, A., and Marai, L. (1967) Lipids 2, 217–224.
Glass, R.L. (1971) Lipids 6, 919–925.
Litchfield, C. (1972) Analysis of Triglycerides, pp. 248–261, Academic Press, New York.
Possmayer, F., Scherphof, G.L., Dubbelman T.N.A.R., and Van Deenen, L.L.M. (1969) Biochim. Biophys. Acta 176, 95–110.
Huebscher, G. (1970) in Lipid Metabolism (Wakil, S.J., ed.) pp. 279–370, Academic Press, New York, NY.
Higgins, J.A., and Barnett, R.J. (1971) J. Cell Biol. 50, 102–120.
Ellingboe, J., and Steinberg, D. (1972) Biochim. Biophys. Acta 270, 92–102.
Mattson, F.H., and Streck, J.A. (1974) J. Nutr. 104, 483–488.
Mattson, F.H., Nolen, G.A., and Webb, M.R. (1979) J. Nutr. 109, 1682–1687.
Sanders, T.H. (1979) Lipids 14, 630–633.
Van Pee, W., Van Hee, J., Boni, L., and Hendrikx, A. (1979) J. Am. Oil Chem. Soc. 56, 901–903.
Hokes, J.C., and Worthington, R.E. (1979) J. Am. Oil Chem. Soc. 56, 953–956.
Author information
Authors and Affiliations
About this article
Cite this article
Manganaro, F., Myher, J.J., Kuksis, A. et al. Acylglycerol structure of genetic varieties of peanut oils of varying atherogenic potential. Lipids 16, 508–517 (1981). https://doi.org/10.1007/BF02535049
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02535049